The alterations in the hemostatic balance in COVID‐19 patients are strongly disturbed and
contribute to a high prothrombotic status. The high rate of venous thromboembolism in …

Introduction Patients with COVID‐19 are known to have a coagulopathy with a thrombosis
risk. It is unknown whether this is due to a generalized humoral prothrombotic state or …

COVID-19 disease has led to an extraordinary inclusive health crisis globally. Elevation of D-
dimer is the major remarkable abnormal coagulation test in seriously ill COVID-19 patients …

Patients with COVID-19 are known to be at risk of developing both venous, arterial and
microvascular thrombosis, due to an excessive immuno-thrombogenic response to the …

The COVID‐19 pandemic has become an urgent issue in every country. Based on recent
reports, the most severely ill patients present with coagulopathy, and disseminated …

The SARS-CoV-2 virus caused a global pandemic within weeks, causing hundreds of
thousands of people infected. Many patients with severe COVID-19 present with coagulation …

Background Abnormal coagulation parameters have been reported in COVID‐19‐infected
patients. Although the underlying mechanism of COVID‐19 coagulopathy remains unknown …

This data article accompanies the manuscript entitled:“Prothrombotic Disturbances of
hemostasis of Patients with Severe COVID-19: a Prospective Longitudinal Observational …

The pandemic of a novel coronavirus infection COVID-19 has become a real challenge to
the mankind and medical community and has raised a number of medical and social issues …

Abstract Severe coronavirus disease-19 (COVID-19) has been associated with fibrin-
mediated hypercoagulability and thromboembolic complications. To evaluate potential …